111 related articles for article (PubMed ID: 7784260)
21. Monoclonal immunoradiometric assay of calcitonin improves investigation of familial medullary thyroid carcinoma.
Perdrisot R; Bigorgne JC; Guilloteau D; Jallet P
Clin Chem; 1990 Feb; 36(2):381-3. PubMed ID: 2302785
[TBL] [Abstract][Full Text] [Related]
22. Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements.
Engelbach M; Görges R; Forst T; Pfützner A; Dawood R; Heerdt S; Kunt T; Bockisch A; Beyer J
J Clin Endocrinol Metab; 2000 May; 85(5):1890-4. PubMed ID: 10843170
[TBL] [Abstract][Full Text] [Related]
23. Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects.
Karanikas G; Moameni A; Poetzi C; Zettinig G; Kaserer K; Bieglmayer C; Niederle B; Dudczak R; Pirich C
J Clin Endocrinol Metab; 2004 Feb; 89(2):515-9. PubMed ID: 14764755
[TBL] [Abstract][Full Text] [Related]
24. Routine measurement of plasma calcitonin in nodular thyroid diseases.
Vierhapper H; Raber W; Bieglmayer C; Kaserer K; Weinhäusl A; Niederle B
J Clin Endocrinol Metab; 1997 May; 82(5):1589-93. PubMed ID: 9141554
[TBL] [Abstract][Full Text] [Related]
25. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
[TBL] [Abstract][Full Text] [Related]
26. Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?
Pina G; Dubois S; Murat A; Berger N; Niccoli P; Peix JL; Cohen R; Guillausseau C; Charrie A; Chabre O; Cornu C; Borson-Chazot F; Rohmer V;
Clin Endocrinol (Oxf); 2013 Mar; 78(3):358-64. PubMed ID: 22913268
[TBL] [Abstract][Full Text] [Related]
27. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
[TBL] [Abstract][Full Text] [Related]
28. Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families.
Wion-Barbot N; Schuffenecker I; Niccoli P; Conte-Devolx B; Lecomte P; Houdent C; Bigorgne JC; Modigliani E
Ann Endocrinol (Paris); 1997; 58(4):302-8. PubMed ID: 9436479
[TBL] [Abstract][Full Text] [Related]
29. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer.
Colombo C; Verga U; Mian C; Ferrero S; Perrino M; Vicentini L; Dazzi D; Opocher G; Pelizzo MR; Beck-Peccoz P; Fugazzola L
J Clin Endocrinol Metab; 2012 Mar; 97(3):905-13. PubMed ID: 22170709
[TBL] [Abstract][Full Text] [Related]
30. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
[TBL] [Abstract][Full Text] [Related]
31. Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma.
Wells SA; Baylin SB; Johnsrude IS; Harrington DP; Mendelsohn G; Ontjes DJ; Cooper CW
Ann Surg; 1982 Nov; 196(5):505-11. PubMed ID: 7125737
[TBL] [Abstract][Full Text] [Related]
32. A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma.
Kwon H; Kim WG; Choi YM; Jang EK; Jeon MJ; Song DE; Baek JH; Ryu JS; Hong SJ; Kim TY; Kim WB; Shong YK
Clin Endocrinol (Oxf); 2015 Apr; 82(4):598-603. PubMed ID: 25041034
[TBL] [Abstract][Full Text] [Related]
33. RT-PCR-based detection of circulating calcitonin-producing cells in patients with advanced medullary thyroid cancer.
Saller B; Feldmann G; Haupt K; Broecker M; Janssen OE; Roggendorf M; Mann K; Lu M
J Clin Endocrinol Metab; 2002 Jan; 87(1):292-6. PubMed ID: 11788662
[TBL] [Abstract][Full Text] [Related]
34. Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease.
Herrmann BL; Schmid KW; Goerges R; Kemen M; Mann K
Eur J Endocrinol; 2010 Jun; 162(6):1141-5. PubMed ID: 20332126
[TBL] [Abstract][Full Text] [Related]
35. Calcitonin levels by ECLIA correlate well with RIA values in higher range but are affected by sex, TgAb, and renal function in lower range.
Ito Y; Kaneko H; Sasaki Y; Ohana N; Ichijo M; Furuya F; Suzuki S; Suzuki S; Shimura H
Endocr J; 2020 Jul; 67(7):759-770. PubMed ID: 32269183
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of an immunoassay for calcitonin].
Sylla Niang M; Lombardo F; Schlumberger M; Bidart JM
Dakar Med; 2008; 53(1):76-83. PubMed ID: 19102121
[TBL] [Abstract][Full Text] [Related]
37. Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer.
Machens A; Hoffmann F; Sekulla C; Dralle H
Endocr Relat Cancer; 2009 Dec; 16(4):1291-8. PubMed ID: 19726541
[TBL] [Abstract][Full Text] [Related]
38. Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery.
Schott M; Willenberg HS; Sagert C; Nguyen TB; Schinner S; Cohnen M; Cupisti K; Eisenberger CF; Knoefel WT; Scherbaum WA
Clin Endocrinol (Oxf); 2007 Mar; 66(3):405-9. PubMed ID: 17302876
[TBL] [Abstract][Full Text] [Related]
39. "Hook effect" in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: case report and review of the literature.
Leboeuf R; Langlois MF; Martin M; Ahnadi CE; Fink GD
J Clin Endocrinol Metab; 2006 Feb; 91(2):361-4. PubMed ID: 16278263
[TBL] [Abstract][Full Text] [Related]
40. Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study.
Papi G; Corsello SM; Cioni K; Pizzini AM; Corrado S; Carapezzi C; Fadda G; Baldini A; Carani C; Pontecorvi A; Roti E
J Endocrinol Invest; 2006 May; 29(5):427-37. PubMed ID: 16794366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
